Vascular mortality in participants of a bipolar genomics study
Jess G Fiedorowicz1, Dubravka Jancic2, James B Potash2
1Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA; Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA; Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA.
Insights
Longer depressive episodes in bipolar disorder significantly increase the risk of vascular mortality. This suggests mood disorders accelerate cardiovascular and cerebrovascular death in a dose-dependent manner.
Area of Science:
- Psychiatry
- Cardiology
- Epidemiology
Background:
- Previous research linked symptom burden in bipolar disorder to adverse vascular outcomes.
- This study aimed to confirm these findings using a practical measure of mood disorder duration and vascular mortality.
Purpose of the Study:
- To investigate the association between the duration of depressive and manic episodes and vascular mortality in individuals with bipolar I disorder.
- To replicate prior findings on the relationship between mood disorder chronicity and vascular outcomes.
Main Methods:
- Mortality assessment of 1716 participants with bipolar I disorder using the National Death Index.
- Cox proportional hazards models were used to analyze the relationship between episode duration and time to vascular mortality, adjusting for covariates.
Main Results:
- Over a mean follow-up of 7 years, 18 vascular deaths occurred among 58 total deaths.
- Longer duration of severe depressive episodes was significantly associated with increased vascular mortality (HR=1.16, p=0.02).
- The duration of manic episodes did not show a significant association with vascular mortality.
Conclusions:
- The duration of severe depression independently predicts vascular mortality in bipolar disorder.
- Findings support the hypothesis that mood disorders accelerate vascular mortality in a dose-dependent manner.
- Further research into mechanisms and integrated treatment strategies for mood and cardiovascular risk factors is recommended.
Background:
In prior work, we identified a relationship between symptom burden and vascular outcomes in bipolar disorder.
Objective:
We sought to replicate these findings using a readily accessible measure of mood disorder chronicity and vascular mortality.
Methods:
We conducted a mortality assessment using the National Death Index for 1716 participants with bipolar I disorder from the National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium. We assessed the relationship between the duration of the most severe depressive and manic episodes and time to vascular mortality (cardiovascular or cerebrovascular) using Cox proportional hazards models, adjusting for potentially confounding variables.
Results:
Mortality was assessed a mean for 7 years following study intake, at which time 58 participants died, 18 of vascular causes. These participants had depression for much longer than their counterparts did (Wilcoxon rank sum Z = 2.30, p = 0.02) and the duration of the longest depressive episode in years was significantly associated with time to vascular mortality in models (hazard ratio = 1.16, 95% confidence interval: 1.02-1.33, p = 0.02), which controlled for age, gender, vascular disease equivalents, and vascular disease risk factors. The duration of longest mania was not related to vascular mortality.
Conclusion:
The duration of the most severe depression is independently predictive of vascular mortality, lending further support to the idea that mood disorders hasten vascular mortality in a dose-dependent fashion. Further study of the relevant mechanisms by which mood disorders may hasten vascular disease and of integrated treatments for mood and cardiovascular risk factors is warranted.
Related Concept Videos
Bipolar Disorder
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Longitudinal Studies

